NCT00405730

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Ocular Pain Associated With Cataract Surgery: European Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 227 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment of ocular inflammation and ocular pain after cataract extraction with IOL implantation

Conditions

• Cataracts

Interventions

Type	Name	Description
DRUG	Nepafenac 1mg/ml eye drops, suspension	One drop in the study eye 3 times daily for 23 days
DRUG	Ketorolac Trometamol 5 mg/ml eye drops, solution	One drop in the study eye 3 times daily for 23 days
OTHER	Nepafenac vehicle eye drops	One drop in the study eye 3 times daily for 23 days

Timeline

• Start date: 2005-11-01
• Primary completion: 2006-07-01
• Completion: 2006-07-01
• First posted: 2006-11-30
• Last updated: 2016-11-18

Locations

1 site across 1 country: France